tirzepatide patent expiry in india Looming GLP-1 drug expirations draw generics firms Amid GLP-1 drugs going viral,

In this episode, I sit down with Lyle McDonald to break down what the science actually shows about metabolism and fat loss during the menopause transition

As suggested by the authors, E

Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study

In 2021, the FDA approved a third semaglutide formulation, Wegovy, for chronic weight management for those with obesity or overweight and at least one weight-related condition

You don't have to wait a half hour before you can have anything after

October 2023: A study suggested that patients with obesity who took Glucagon-like Peptide-1 Receptor Agonists (such as Ozempic) for weight loss had a higher risk of gastroparesis than those in the dataset who took bupropion-naltrexone